Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Lyophilized formulation of stem cell-derived exosomes and anti-inflammatory composition including the same as active ingredient

Lyophilized formulation of stem cell-derived exosomes and anti-inflammatory composition including the same as active ingredient

US Patent 11529306 · Granted Dec 20, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Electrically heated mixer assembly for an exhaust aftertreatment system2025
Semiconductor device with deep trench isolation2025
Material transport hand, material transport device, and material transport metho2025
Control method of electronic device for providing evaluation information of essa2024
Semiconductor device including nonvolatile memory device and logic device and ma2024
Composition comprising sapogenin and exosome as effective ingredient2023
Composition comprising sapogenin and exosome as effective ingredient2023
Tissue staining composition and tissue staining method using same2023
Composition for alleviating facial redness, comprising stem cell-derived exosome2023
Composition for alleviating facial redness, comprising stem cell-derived exosome2023
Cosmetic composition comprising rose stem cell-derived exosome as effective ingr2023
Cosmetic composition comprising rose stem cell-derived exosome as effective ingr2023